= Abstract = Purpose : The aims of this study were to investigate the long-term outcomes in children with infantile spasms (IS) and to identify the prognostic factors influencing their neurodevelopment. Methods : We retrospectively evaluated seventy two children over five years old who were treated for IS at Asan Medical Center, Seoul, Korea, between 1994 and 2007. Forty-three children were contacted by telephone or medical follow-up to assess their current neurodevelopmental status. Multiple logistic regression was used to calculate odds ratios (ORs) and 95% confidence interval (95% CIs) of risk factors for unfavorable outcomes. Results : The mean follow-up duration for these 43 children was 7.2±1.5 years (range, 4.5 to 13.0 years). Of these, 13 (30.2%) had cryptogenic and 30 (69.8%) had symptomatic IS. Eleven (25.6%) children were initially treated with adrenocorticotrophic hormone (ACTH) therapy, with a mean treatment lag of 1.3±1.9 months (range; 0.1 to 7.0 months). Eighteen (41.8%) children clinically responded to initial treatment, as shown by EEG response. Overall, 22 (51.2%) children had at least moderate neurodevelopmental disorders and 2 (4.8%) died. In univariate analysis, etiology (symptomatic) and poor electroclinical response to initial treatment were related to long-term unfavorable outcomes. In multivariate analysis, response to primary treatment was the sole significant independent risk factor with a high OR. Conclusion : Overall prognosis of children with IS was poor. Electroclinical non-responsiveness to initial treatment was related to unfavorable long-term outcomes, indicating that initial control of seizures may be important in reducing the likelihood of poor neurodevelopment. (Korean J Pediatr 2010;53:80-84) 
Introduction
Infantile spasm (IS), one of the most common forms of epileptic encephalopathy, is a childhood syndrome characterized by specific epileptic seizures and a specific electroencephalography (EEG) pattern, as well as being one of the major causes of acquired mental retardation and neurodevelopmental disorders in early childhood 1, 2) . It is conventional thought that persistent spasm and hyperarrhythmia inhibit the normal development and growth of the brain, predisposing toward neurodevelopmental delays even after the cessation of seizures 3) . Accordingly, early and initial control of spasms and abnormal EEG waves may be the cornerstone of IS treatment to prevent cognitive and psychosocial dysfunction, while resistance to treatment and transition to other types of seizure have been clinically problematic 3, 4) . Many studies have investigated the long-term outcomes in patients with IS and the factors prognostic of poor neurodevelopment [3] [4] [5] [6] [7] . Underlying etiology, pre-existing developmental delay, response to initial treatment, and treatment lag (lead time from apparent onset to treatment initiation) have been cited as the major risk factors for poor neurodevelopment and/or mental retardation [3] [4] [5] [6] [7] . The natural history of IS, however, has not been determined and most factors prognostic of poor outcome have been identified from retrospective and heterogeneous studies, including different populations and different treatment regimens 6) . In 2001, the West Delphi Group 8) proposed a consensus 
Materials and methods
The study population included 76 children with IS, aged >5 years at the time of data collection, treated at Asan Medical Center, Seoul, Korea, between January 1994 and January 2007. The medical records and computerized databases of these children were reviewed retrospectively.
The terminology and selection of variables were based on study guidelines proposed by the West Delphi Group 8) . The following characteristics were selected: age at onset (cor- . Long-term outcomes included death and unfavorable neurodevelopment (i.e. moderate to severe mental retardation or neurodevelopmental disorder), which were assessed using questionnaires and medical records. The questionnaires included questions related to academic underachievement, behavioral and/or emotional difficulties, physical restrictions or degree of self-care, and concerns about visual and auditory disturbances 10) . Multiple logistic regression was used to calculate odds ratios (ORs) and 95% confidence intervals (95% CIs) for risk factors for unfavorable outcomes, using SPSS software (SPSS for Windows, Release 14.0; SPSS Inc., Chicago, IL, USA). A P value less than 0.05 was considered statistically significant.
Results
Of the 76 children with IS, 43 could be contacted by hospital visit or telephone for assessment of their neurodevelopmental status. The mean age of these 43 children at the time of data collection was 9.6±2.4 years (range, 5.0 to 13.2 years) and the mean follow-up time was 7.2±1.5 years (range, 4.5 to 13.0 years). Table 1 shows the etiologic classification of the population. Of these 43 children, 13 (30.2%) had cryptogenic and 30 (69.8%) had symptomatic IS. Of the 30 children with symptomatic IS, 14 (46.7 %) had perinatal disorders, 13 (43.3%) had congenital abnormalities, 2 (6.7%) had nervous system disorders, and 1 (3.3%) had a neoplasm. Table 2 shows the characteristics of the study population. The mean age at seizure onset was 5.0±3.8 months were significantly related to unfavorable outcomes (Table   3 ). In multivariate analysis, response to primary treatment was the sole significant independent risk factor for unfavorable outcome, with a high OR (P =0.023, OR=20.47, 95% CI=1.93 to 160.98).
Discussion
Since the first description of IS in 1841 11) , this disorder has been of great interest to clinicians because of its association with poor long-term neurodevelopment. IS is a rare form of epileptic encephalopathy characterized by specific epileptic seizures and specific EEG patterns, known as hypsarrhythmia 12) . IS is rare with a frequency of 0.16 to 0.42 per 1,000 live births 13) and accounting for 2-3% of children with childhood seizures 14) . In Korea, however, . Hypsarrhythmia consists of chaotic patterns of high voltage spikes, bilateral asynchrony, and slow-wave activity 2, [12] [13] [14] . EEG patterns characteristic of IS are more likely to occur during early stages of IS or in younger patients [12] [13] [14] . ACTH has been shown to resolve spasms faster than vigabatrin, although evidence of longterm benefits of ACTH in the prevention of neurodevelopmental disorders has been insufficient in a recent Cochrane study 15) . IS is frequently characterized by unfavorable neurodevelopmental outcomes, treatment resistance, frequent relapse, and transition to other forms of seizures, with 80%
to 90% of children with IS developing mental retardation as adults 16) . A study of 147 children with IS showed that only 36% were seizure free, whereas 18% presented with Lennox-Gastaut syndrome, and 76% had moderate to severe mental retardation (IQ less than 68) 3) . In most patients, the IQ of adults was similar to that determined at a mean age of 8 years, whereas IQ level decreased among children with drug-resistant epilepsy. In another study, 83
% of 10-year-old children with a history of IS had mental retardation (IQ≤70) and 56% had profound mental retardation (IQ≤20) 17) . Our results are consistent with these findings, in that 72.1% (n=31) of our children with IS had at least mild neurodevelopmental disorders or died and 46.5 % (n=20) had moderate to severe neurodevelopmental disorders. In addition, both patients who died suffered from severe physical restrictions before death.
Because of poor prognosis despite treatment, identification of risk factors predisposing to poor long-term outcomes, including neurodevelopment disorders and mortalities has been one of main issues [3] [4] [5] [6] [7] . Despite the incon- . For example, severe brain malformation, postinfectious etiology 18) , and tuberous sclerosis 19) have been associated with more unfavorable prognosis. In contrast, patients with cryptogenic etiology, in which no causes can be identified, have a good prognosis. We found that 39.5% of children with symptomatic IS, but only 11.7% of those with cryptogenic IS, had unfavorable outcomes. In addition, none of the children with cryptogenic IS had a severe neurodevelopmental disorder.
Statistical analysis showed that the difference between the symptomatic and cryptogenic groups approached statistical significance at the univariate, but not at the multivariate level (Table 3) . We surmise that successful neurosurgery for intractable epilepsy and vigabatrin for tuberous sclerosis, which are known to be particularly effective 20, 21) , may have weakened the association between etiology and long-term outcome. Of the 5 children with symptomatic IS who underwent neurosurgery, 4 showed normal neurodevelopment or mild developmental disorders. Of the 72 children with IS, four had tuberous sclerosis and were treated with vigabatrin; of these, 1 developed normally and 3 were lost to follow-up, but 2 of these 3 children showed cessation of spasms after initial treatment.
Another prognostic factor is primary clinical and electroclinical outcomes [3] [4] [5] [6] [7] . A study in a large population found that 97.0% of patients with favorable long-term outcomes were electroclinical responders to initial treatment 3) . We found that non-response to primary treatment was significantly related to neurodevelopmental disorders with high OR in both univariate and multivariate analysis ( Table 4 ).
The prevalence of unfavorable outcomes in non-responders was two-fold higher than in responders. Furthermore, non-responders with symptomatic IS had the highest prevalence of unfavorable outcomes.
We found that the remaining risk factors, including developmental delay at time of diagnosis and treatment lag,
were not related to neurodevelopmental outcomes. Children with pre-existing developmental delay or neurological deficits at time of diagnosis have been thought to be related to less favorable developmental outcomes 8) . This tendency may be related to the association between the underlying causes of IS and pre-existing developmental disorders.
Children with symptomatic IS had a higher prevalence of pre-existing developmental delay. Although it is not clear if treatment lag is a risk factor, several reports have emphasized the importance of rapid treatment initiation 22, 23) . A study of 286 children with IS found that initiation of treatment within 30 days was significantly related to better long-term outcomes than initiation after 30 days 23) .
In conclusion, despite this study suffers from a small 
